86 related articles for article (PubMed ID: 12041759)
1. In-vitro activity of quinolones against different species of staphylococci of recent clinical isolation.
Rabagliati AM; Fiorio P; Cavallo R; Mills V; Penna R
J Chemother; 1991 Jan; 3 Suppl 1():176-8. PubMed ID: 12041759
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
3. [Activity of ofloxacin and other fluoroquinolones against staphylococcus which is either resistant to or susceptible to methicillin].
Gospodarek E; Wojak I
Med Dosw Mikrobiol; 1994; 46(4):237-46. PubMed ID: 7603125
[TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
Watanabe S; Ito T; Hiramatsu K
J Antimicrob Chemother; 2007 Dec; 60(6):1384-7. PubMed ID: 17890283
[TBL] [Abstract][Full Text] [Related]
5. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
6. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
Noviello S; Ianniello F; Leone S; Esposito S
J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
[TBL] [Abstract][Full Text] [Related]
8. [In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus].
Tronel H; Voiriot P; Weber M; Dopff C; Dewachter P; Phelisse F; Dureux JB
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):578-81. PubMed ID: 2797882
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
[TBL] [Abstract][Full Text] [Related]
10. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.
Metzler K; Hansen GM; Hedlin P; Harding E; Drlica K; Blondeau JM
Int J Antimicrob Agents; 2004 Aug; 24(2):161-7. PubMed ID: 15288315
[TBL] [Abstract][Full Text] [Related]
11. [Short communication: Determination of methicillin resistance in staphylococci with different methods and detection of multiple antibiotic resistance].
Cetinkol Y; Altindiş M; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2008 Jan; 42(1):119-24. PubMed ID: 18444569
[TBL] [Abstract][Full Text] [Related]
12. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.
Asbell PA; Colby KA; Deng S; McDonnell P; Meisler DM; Raizman MB; Sheppard JD; Sahm DF
Am J Ophthalmol; 2008 Jun; 145(6):951-958. PubMed ID: 18374299
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria.
Oni AA; Bakare RA; Arowojolu AO; Kehinde Toki RA; Fasina NA
Afr J Med Med Sci; 2001; 30(1-2):35-7. PubMed ID: 14510147
[TBL] [Abstract][Full Text] [Related]
14. In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():35-41. PubMed ID: 3144547
[TBL] [Abstract][Full Text] [Related]
15. In vitro antimicrobial interactions of arthemeter with some 4-quinolones.
Esimone CO; Adikwu MU; Nwafor SV; Okoli CO; Ndu OO; Nwoke OI
Boll Chim Farm; 2002; 141(5):385-8. PubMed ID: 12481382
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
17. Development of clinically important resistance to quinolones and other antibiotic groups.
Lode H
J Int Med Res; 1990; 18 Suppl 4():27D-36D. PubMed ID: 2282967
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia.
Gebre-Sealsssie S
Ethiop Med J; 2007 Oct; 45(4):363-70. PubMed ID: 18326346
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of hydrophobic xanthones from Cudrania cochinchinensis against Bacillus subtilis and methicillin-resistant Staphylococcus aureus.
Fukai T; Oku Y; Hou AJ; Yonekawa M; Terada S
Chem Biodivers; 2004 Sep; 1(9):1385-90. PubMed ID: 17191916
[TBL] [Abstract][Full Text] [Related]
20. [Study on the resistance of methicillin-resistant staphylococcus aureus to iodophor and chlorhexidine].
Zhang YH; Liu XY; Zhu LL; Yu YZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):248-50. PubMed ID: 15200941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
